Specifically, CD4‐c02‐Itgb1 cells were linked to tumor‐enriched Tcm (CD4‐c05‐S1pr1) cells and Ifng+ Th1 (CD4‐c06‐Bhlhe40) cells based on STARTRAC‐tran indices (Figure 3I). Here, ITGB1 is linked to neoplasm.